8/7/2019 drugstudy%20ni%20sara[1]

http://slidepdf.com/reader/full/drugstudy20ni20sara1 1/7

Part IV ± ANNEX 1

PRESCRIBED MEDICATION: TACTIS

NAME OF PATIENT                                                 : __________________________

AGE & SEX                                                                 : _____

CLINICAL AREA/ ROOM NO.                                : ________________________________________________

MEDICATIONS TRADE/ GENERIC                      :Metronidazole _______________________________ 

DOSE/ ROUTE/ FREQUENCY                                :500 mg IV q 6

________________________________ 

PHARMACOLOGICAL CLASSIFICATION         :antibacterial_________________________________  why is the client receiving the drug?                         :For antibacterial_______________________________ 

    

T

Therapeutic Classification

 

 

 

A

Action

 

C

Contraindication

 

T

Toxic/ Side Effects

 

I

Interventions

 

  

 Antibacterial & Anti-parasitic

 

  

A direct actingtrichomonacide & amebic

idée that works @ bothintestinal & extra intestinal.

 

  

 Contraindicated  to

hypersensitivity

 

  

Vertigo, headache, ataxia,irritability, abdominal

cramping, in coordination,confusion, nausea,

vomiting, anorexia,diarrhea, constipation

 

Give oral form w/ meals tominimize GI distress.

 Tell pt. metallic taste &

dark or red brown urinemay occur.

 The IV form should be

administered by slowinfusion only.

 Tell pt. to avoid alcohol or 

alcohol containingmedications during therapy

& for @ least 48 hours after therapy is completed.

 

 500

8/7/2019 drugstudy%20ni%20sara[1]

http://slidepdf.com/reader/full/drugstudy20ni20sara1 2/7

 

 

T

Therapeutic Classification/

Name of drugs/ Dosage 

 

A

Action

 

C

Contraindication

 

T

Toxic/ Side Effects

 

I

Interventions Sa

  

  

Anti - Infectives 

Clindamycin Hydrochloride 

 300 mg IV q 6

  

  

Inhibits bacterial proteinsynthesis by binding to the

50s subunit of theribosome.

  

  

Contraindicated in patientwith known

hypersensitivity to theantibiotic congener 

linomycin.

  

  

Nausea, vomiting,abdominal pain, diarrhea,

rash, urticaria .

  

 Monitor renal, hepatic &

hematopoietic functionsduring prolonged therapy

 Don¶t use in meningitis

 Instruct pt. to report

adverse reactions to thedoctor especially diarrhea

 Advice pt¶s taking the

capsule form to take with afull glass of water to

prevent dysphasia. 

Give deep I.M. rotate siteswarn that I.M. injection

may be painful.

  

300 m 

  

  

  

 

8/7/2019 drugstudy%20ni%20sara[1]

http://slidepdf.com/reader/full/drugstudy20ni20sara1 3/7

  

 

T

Therapeutic Classification/

Name of drugs/ Dosage 

 

A

Action

 

C

Contraindication

 

T

Toxic/ Side Effects

 

I

Interventions Sa

 

  

 Penicillins

 

Piperacillin + Tazobactam 2.25 mg IV q 12 ANST (-)

 

  

 Bacteria against

microorganisms by

inhibiting cell wallsynthesis during activemultiplication. Bacteria

resist penicillin byproducing penicillinases.

 

  

 Hypersensitivity to

penicillin¶s, cephalosporin¶s

or B-Lactamase inhibitors.

 

  

 Headache, seizures,

dizziness, irritability,

neuromuscular, nausea,vomiting

 

  

Before giving pipercillinask pt. if he¶s any allergic

reactions to penicillin.

 Check CBC & plateletsfrequency. Drug may cause

thrombocytopenia. 

Monitor serum potassiumlevel.

 

Give I.V. intermittently toprevent vein irritation 

Give piperacillin @ lest 1hour before bacteriostatic

antibiotics.

 

  

2.25 mg IV q

8/7/2019 drugstudy%20ni%20sara[1]

http://slidepdf.com/reader/full/drugstudy20ni20sara1 4/7

 

T

Therapeutic Classification/

Name of drugs/ Dosage 

 

A

Action

 

C

Contraindication

 

T

Toxic/ Side Effects

 

I

Interventions S

  

 Anti diabetic agent

 Humulin  N

 50-100 ³U´ q 6

  

 Increase glucose transport

across muscle & fat cellmembranes to reduce blood

glucose level.

  

 Contraindicated to

hypoglycemia IVadministration

hyperglycemic coma.

  

 Itching, swelling, redness,

stinging, warmth @ site of injection

  

 Instruct patient about nature

of disease the importance of following the therapeutic

regimen, adhering to specificdiet.

 Advise patient to wear 

medical identification alert@ all times.

 Instruct patients on proper 

use of equipment for performing self monitoring

of blood glucose. 

Check expiration date onvial before using contents.

  

  

50 ± 100

8/7/2019 drugstudy%20ni%20sara[1]

http://slidepdf.com/reader/full/drugstudy20ni20sara1 5/7

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

8/7/2019 drugstudy%20ni%20sara[1]

http://slidepdf.com/reader/full/drugstudy20ni20sara1 6/7

 

T

Therapeutic Classification/

Name of drugs/ Dosage

 

 

A

Action

 

C

Contraindication

 

T

Toxic/ Side Effects

 

I

Interventions

 

  

 

Anti Diabetic Agent 

Insulin

( Ecophene InsulinSuspension)

  

100 units/ ml in 1.5 ml

cartridge system

 

  

 

Promotes conversion of glucose to its storage form,glycogen; triggers amino

acid uptake and conversionto protein in muscle cells

and inhibits protein indegradation.

 

  

 

Contraindicated tohypoglycemia.

 

  

 

Lip atrophy, itching,swelling, redness, stinging,anaphylaxis

 

  

Use only regular insulin in

patient with circulatingcollapse, diabeticketoacidosis, or 

hyperkalemia. Do not usereg. insulin concentrated I.V.

 Advice patient not to alter 

the order of mixing insulin¶s

or changed the model or brand of syringe or needle.

 Store insulin cool area.

 Don¶t use insulin that has

changed color or becomesclumped or granular in

appearance. 

Regular insulin should not bemixed with globins insulin.

  

 

  

100 ³

ca

8/7/2019 drugstudy%20ni%20sara[1]

http://slidepdf.com/reader/full/drugstudy20ni20sara1 7/7